Browsing by Author "Bartoš Jiří"
Now showing 1 - 20 of 21
Results Per Page
Sort Options
- ItemAxitinib in the Metastic Treatment Renal Cancer(2017-01-01) Richter Igor; Dvořák Josef; Hejzlarová Věra; Bartoš Jiří
- ItemBirateron in the Therapy of Metastic Castratin Resistant Cardinal Prostate Before Immediately of Chemotherapy(2017-01-01) Richter Igor; Dvořák Josef; Bartoš Jiří; Hejzlarová Věra; Barsová Lucie; Forster J.
- ItemDocetaxel-Kabazitaxel-Enzalutamide Sequence vs Docetaxel-Enzalutamide Sequence in Patients with Metastatic Cancer Resistant Prostate Cancer(Ambit Media, 2017-01-01) Richter Igor; Dvořák Jiří; Bartoš Jiří
- ItemEnzalutamide in Patients Metastic Kastračně Resistant Cartridge Prosthes After Previous Chemotherapy Therapy(2017-01-01) Richter Igor; Dvořák Josef; Hejzlarová Věra; Bartoš Jiří
- ItemEnzalutamide in the treatment of metastatic castrationally-resistant prostate cancer following previous chemotherapy(Current Media, 2017-01-01) Richter Igor; Dvořák Josef; Hejzlarová V.; Bartoš Jiří
- ItemExpression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma(Zerbinis Medical Publications, 2019-01-01) Richter Igor; Jirásek Tomáš; Čermáková Eva; Bartoš Jiří; Buchler Tomáš; Dvořák Josef
- ItemExtraction of Liver Conditions in Enzalutamide Treated by Enzalutamide - Causes(2017-01-01) Richter Igor; Dvořák Josef; Bartoš Jiří; Forster J.
- ItemFirst-line treatment of metastatic renal cell carcinoma(Current Media s.r.o., 2019-01-01) Richter Igor; Dvořák Josef; Bartoš Jiří; Šámal Vladimír
- ItemInfluence of neoadjuvant chemoradiotherapy on PD-L1 expression change in rectal cancer patients(Current Media s.r.o., 2019-01-01) Richter Igor; Dvořák Josef; Bartoš Jiří; Jirásek Tomáš
- ItemOwn experience with axitinib in the treatment of metastatic renal cell carcinoma(Solen, 2018-01-01) Richter Igor; Dvořák Josef; Šámal Vladimír; Hejzlarová Věra; Bartoš Jiří
- ItemPacific care in KOC Liberec - first experience after the termination of the project together to the end(2017-01-01) Hrstková Dana; Bartoš Jiří; Sochor Marek
- ItemPalliative care applied together with oncology treatment in patients with advanced tumors(Current Media, s.r.o., 2017-01-01) Sochor Marek; Bartoš Jiří
- ItemPatients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers(Palacky University Olomouc, 2020-01-01) Richter Igor; Poprach Alexandr; Zemánková Anežka; Buchler Tomáš; Bartoš Jiří; Šámal Vladimír; Rozsypalová Aneta; Dvořák Josef; Brom Ondřej; Melichar Bohuslav; Studentová Hana
- ItemPossibilities of chemotherapy in the treatment of prostate cancer(Ambit Media, 2017-01-01) Richter Igor; Dvořák Josef; Bartoš Jiří
- ItemPrognostic effect of PD-L1 expression changes in patients treated with neoadjuvant chemoradiotherapy for rectal adenocarcinoma(2018-01-01) Richter Igor; Dvořák Jiří; Jirásek Tomáš; Řeháková Petra; Bartoš Jiří
- ItemThe status of bevacizumab in the treatment of colorectal cancer(Current media, 2018-01-01) Richter Igor; Dvořák Josef; Bartoš Jiří
- ItemStrategies sequential treatment of metastatic castration-resistant prostate cancer(2020-01-01) Richter Igor; Šámal Vladimír; Bartoš Jiří; Dvořák Josef
- ItemThe expression of PD-L1 in patients with castrate prostate cancer treated by enzalutamide(2018-01-01) Richter Igor; Jirásek Tomáš; Havlíčková Ivana; Čurčíková Radmila; Šámal Vladimír; Dvořák Josef; Bartoš Jiří
- ItemThe prognostic effect of neoadjuvant chemoradiotherapy on the change of PD-L1 expression in patients with locally advanced rectal adenocarcinoma(Zerbinis Medical Publications, 2017-01-01) Richter Igor; Jirásek Tomáš; Dvořák Josef; Čermáková Eva; Řeháková Petra; Bartoš Jiří
- ItemTwo Years of Experience with Abiraterone in Patients with Castration-Resistant Prostate Cancer - Indications before Chemotherapy(2018-01-01) Richter Igor; Dvořák Josef; Bartoš Jiří